307 related articles for article (PubMed ID: 18720457)
21. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
Masuda S
Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
[TBL] [Abstract][Full Text] [Related]
22. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Nielsen TO; Parker JS; Leung S; Voduc D; Ebbert M; Vickery T; Davies SR; Snider J; Stijleman IJ; Reed J; Cheang MC; Mardis ER; Perou CM; Bernard PS; Ellis MJ
Clin Cancer Res; 2010 Nov; 16(21):5222-32. PubMed ID: 20837693
[TBL] [Abstract][Full Text] [Related]
23. Deconstructing the molecular portraits of breast cancer.
Prat A; Perou CM
Mol Oncol; 2011 Feb; 5(1):5-23. PubMed ID: 21147047
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer prognostic classification in the molecular era: the role of histological grade.
Rakha EA; Reis-Filho JS; Baehner F; Dabbs DJ; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Richardson AL; Schnitt SJ; Schmitt FC; Tan PH; Tse GM; Badve S; Ellis IO
Breast Cancer Res; 2010; 12(4):207. PubMed ID: 20804570
[TBL] [Abstract][Full Text] [Related]
25. Molecular classification of breast cancer.
Vuong D; Simpson PT; Green B; Cummings MC; Lakhani SR
Virchows Arch; 2014 Jul; 465(1):1-14. PubMed ID: 24878755
[TBL] [Abstract][Full Text] [Related]
26. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.
Makki J
Clin Med Insights Pathol; 2015; 8():23-31. PubMed ID: 26740749
[TBL] [Abstract][Full Text] [Related]
27. A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.
Sinn HP; Kreipe H
Breast Care (Basel); 2013 May; 8(2):149-54. PubMed ID: 24415964
[TBL] [Abstract][Full Text] [Related]
28. Identification of different subtypes of breast cancer using tissue microarray.
Munirah MA; Siti-Aishah MA; Reena MZ; Sharifah NA; Rohaizak M; Norlia A; Rafie MK; Asmiati A; Hisham A; Fuad I; Shahrun NS; Das S
Rom J Morphol Embryol; 2011; 52(2):669-77. PubMed ID: 21655659
[TBL] [Abstract][Full Text] [Related]
29. Biological subtypes of breast cancer: Prognostic and therapeutic implications.
Yersal O; Barutca S
World J Clin Oncol; 2014 Aug; 5(3):412-24. PubMed ID: 25114856
[TBL] [Abstract][Full Text] [Related]
30. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
Goldhirsch A; Winer EP; Coates AS; Gelber RD; Piccart-Gebhart M; Thürlimann B; Senn HJ;
Ann Oncol; 2013 Sep; 24(9):2206-23. PubMed ID: 23917950
[TBL] [Abstract][Full Text] [Related]
31. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis.
Yamaguchi R; Tanaka M; Kondo K; Yokoyama T; Kaneko Y; Yamaguchi M; Ogata Y; Nakashima O; Kage M; Yano H
Jpn J Clin Oncol; 2010 Aug; 40(8):781-7. PubMed ID: 20444748
[TBL] [Abstract][Full Text] [Related]
32. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
Weigelt B; Baehner FL; Reis-Filho JS
J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
[TBL] [Abstract][Full Text] [Related]
33. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
Weigelt B; Geyer FC; Horlings HM; Kreike B; Halfwerk H; Reis-Filho JS
Mod Pathol; 2009 Nov; 22(11):1401-14. PubMed ID: 19633645
[TBL] [Abstract][Full Text] [Related]
34. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Lehmann BD; Bauer JA; Chen X; Sanders ME; Chakravarthy AB; Shyr Y; Pietenpol JA
J Clin Invest; 2011 Jul; 121(7):2750-67. PubMed ID: 21633166
[TBL] [Abstract][Full Text] [Related]
35. Luminal A Breast Cancer and Molecular Assays: A Review.
Gao JJ; Swain SM
Oncologist; 2018 May; 23(5):556-565. PubMed ID: 29472313
[TBL] [Abstract][Full Text] [Related]
36. Molecular Classification of Breast Cancer.
Tsang JYS; Tse GM
Adv Anat Pathol; 2020 Jan; 27(1):27-35. PubMed ID: 31045583
[TBL] [Abstract][Full Text] [Related]
37. The 2019 World Health Organization classification of tumours of the breast.
Tan PH; Ellis I; Allison K; Brogi E; Fox SB; Lakhani S; Lazar AJ; Morris EA; Sahin A; Salgado R; Sapino A; Sasano H; Schnitt S; Sotiriou C; van Diest P; White VA; Lokuhetty D; Cree IA;
Histopathology; 2020 Aug; 77(2):181-185. PubMed ID: 32056259
[No Abstract] [Full Text] [Related]
38. Breast Cancer: Current Perspectives on the Disease Status.
Fahad Ullah M
Adv Exp Med Biol; 2019; 1152():51-64. PubMed ID: 31456179
[TBL] [Abstract][Full Text] [Related]
39. Tumoral heterogeneity of breast cancer.
Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
[TBL] [Abstract][Full Text] [Related]
40. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
